Meeting at India's Embassy

     

     Guillermo Cleti, LIF’s Director, had a meeting at India’s Embassy in Argentina.
     Amarendra Khatua (India’s Ambassador); Sudhanshu Pandey (Joint Secretary, Department of Commerce - Ministry of Commerce & Industry), P.V. Appaji (Pharmexcil’s General Director)* and Juan Müller (LEM’s Director)** participated in the meeting which took place at India’s Embassy in Buenos Aires.

     Guillermo Cleti gave information about the different API’s that LIF uses to produce medicines. A lot of them are produced by Indian laboratories.
     “We would like to import some API’s directly from India. Today LIF buys these raw materials in the local market. We want to improve our production costs”, said Guillermo Cleti.
     Also, Guillermo Cleti talked about the project for research, development and production of medicines for patients with tuberculosis diseases.
     “Indian laboratories make a lot of these raw materials. In the future, LIF is going to use a lot of them. This contact with Indian laboratories will be very useful when we need to develop our formulas”, said Cleti.
     P.V. Appagy and Sudhanshu Pandey asked Cleti about the LIF’s production of Orphan drugs. He gave information about: the production of ephedrine tablets for only one child with Myasthenia gravis and Hypertonic Saline to use in patients with Cystic Fibrosis.
     Production of biogenerics was another topic in the agenda.

Link with India.
     On February, 2014, Guillermo Cleti travelled to India as one of the members of the Santa Fe Government’s Mission.He had a schedule of meetings with different Indian companies, mainly medicines manufactures and APIs manufacturers.


*Pharmexcil: Pharmaceuticals Export Promotion Council of India.
API’s: Active Pharmaceutical Ingredient.
**LEM SE: Laboratorio de Especialidades Medicinales, Sociedad del Estado. It is the Rosario’s city hall public laboratory.